Ainos, Inc. (NASDAQ:AIMD) Sees Large Growth in Short Interest

Ainos, Inc. (NASDAQ:AIMD) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 23,172 shares, an increase of 107.8% from the November 30th total of 11,153 shares. Based on an average daily trading volume, of 31,273 shares, the short-interest ratio is presently 0.7 days. Approximately 0.5% of the shares of the stock are short sold. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 31,273 shares, the short-interest ratio is presently 0.7 days.

Insider Transactions at Ainos

In related news, major shareholder Carbon Nano Technology Taiwan sold 7,000 shares of the company’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $3.59, for a total value of $25,130.00. Following the completion of the sale, the insider owned 1,037,206 shares of the company’s stock, valued at approximately $3,723,569.54. This represents a 0.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 9.79% of the company’s stock.

Institutional Trading of Ainos

A hedge fund recently bought a new stake in Ainos stock. Two Sigma Investments LP bought a new position in Ainos, Inc. (NASDAQ:AIMD) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned approximately 0.48% of Ainos as of its most recent SEC filing.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on AIMD. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ainos in a report on Monday, December 22nd. Wall Street Zen upgraded Ainos from a “sell” rating to a “hold” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Ainos Price Performance

AIMD stock opened at $1.95 on Friday. The company has a quick ratio of 2.67, a current ratio of 2.96 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $9.40 million, a price-to-earnings ratio of -0.49 and a beta of 2.39. The stock’s fifty day simple moving average is $2.57 and its 200-day simple moving average is $3.01. Ainos has a 52-week low of $1.78 and a 52-week high of $5.00.

Ainos (NASDAQ:AIMD) last released its quarterly earnings data on Thursday, November 13th. The company reported ($0.64) earnings per share for the quarter. The firm had revenue of $0.00 million during the quarter.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.